124 related articles for article (PubMed ID: 21062083)
1. Targeting therapy with mitosomal daunorubicin plus amlodipine has the potential to circumvent intrinsic resistant breast cancer.
Zhang Y; Li RJ; Ying X; Tian W; Yao HJ; Men Y; Yu Y; Zhang L; Ju RJ; Wang XX; Zhou J; Chen JX; Li N; Lu WL
Mol Pharm; 2011 Feb; 8(1):162-75. PubMed ID: 21062083
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells.
Zhang L; Yao HJ; Yu Y; Zhang Y; Li RJ; Ju RJ; Wang XX; Sun MG; Shi JF; Lu WL
Biomaterials; 2012 Jan; 33(2):565-82. PubMed ID: 21983136
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma.
Yu Y; Wang ZH; Zhang L; Yao HJ; Zhang Y; Li RJ; Ju RJ; Wang XX; Zhou J; Li N; Lu WL
Biomaterials; 2012 Feb; 33(6):1808-20. PubMed ID: 22136714
[TBL] [Abstract][Full Text] [Related]
4. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
[TBL] [Abstract][Full Text] [Related]
5. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
[TBL] [Abstract][Full Text] [Related]
6. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells.
Wang XX; Li YB; Yao HJ; Ju RJ; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
Biomaterials; 2011 Aug; 32(24):5673-87. PubMed ID: 21550109
[TBL] [Abstract][Full Text] [Related]
7. The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.
Shao M; Sun SL; Li MH; Li BX; Yu H; Shen ZY; Ren YC; Hao ZF; Chang ND; Peng HS; Yang BF
J Liposome Res; 2012 Jun; 22(2):168-76. PubMed ID: 22428938
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of WGA modified daunorubicin anti-resistant liposomes in treatment of drug-resistant MCF-7 breast cancer.
Liu S; Song XL; Wang YH; Wang XM; Xiao Y; Wang X; Cheng L; Li XT
J Drug Target; 2017 Jul; 25(6):541-553. PubMed ID: 28277825
[TBL] [Abstract][Full Text] [Related]
9. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer.
Zhou J; Zhao WY; Ma X; Ju RJ; Li XY; Li N; Sun MG; Shi JF; Zhang CX; Lu WL
Biomaterials; 2013 May; 34(14):3626-38. PubMed ID: 23422592
[TBL] [Abstract][Full Text] [Related]
10. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery.
Yao HJ; Ju RJ; Wang XX; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
Biomaterials; 2011 Apr; 32(12):3285-302. PubMed ID: 21306774
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals.
Men Y; Wang XX; Li RJ; Zhang Y; Tian W; Yao HJ; Ju RJ; Ying X; Zhou J; Li N; Zhang L; Yu Y; Lu WL
Int J Nanomedicine; 2011; 6():3125-37. PubMed ID: 22163164
[TBL] [Abstract][Full Text] [Related]
12. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
[TBL] [Abstract][Full Text] [Related]
13. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
[TBL] [Abstract][Full Text] [Related]
14. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes.
Shi M; Zhang J; Li X; Pan S; Li J; Yang C; Hu H; Qiao M; Chen D; Zhao X
Int J Nanomedicine; 2018; 13():4209-4226. PubMed ID: 30140154
[TBL] [Abstract][Full Text] [Related]
16. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer.
Ju RJ; Li XT; Shi JF; Li XY; Sun MG; Zeng F; Zhou J; Liu L; Zhang CX; Zhao WY; Lu WL
Biomaterials; 2014 Aug; 35(26):7610-21. PubMed ID: 24912818
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms.
Tophkhane C; Yang S; Bales W; Archer L; Osunkoya A; Thor AD; Yang X
Int J Oncol; 2007 Oct; 31(4):867-74. PubMed ID: 17786319
[TBL] [Abstract][Full Text] [Related]
18. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer.
Jiang PD; Zhao YL; Deng XQ; Mao YQ; Shi W; Tang QQ; Li ZG; Zheng YZ; Yang SY; Wei YQ
Biomed Pharmacother; 2010 Nov; 64(9):609-14. PubMed ID: 20888174
[TBL] [Abstract][Full Text] [Related]
19. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals.
Ying X; Wen H; Lu WL; Du J; Guo J; Tian W; Men Y; Zhang Y; Li RJ; Yang TY; Shang DW; Lou JN; Zhang LR; Zhang Q
J Control Release; 2010 Jan; 141(2):183-92. PubMed ID: 19799948
[TBL] [Abstract][Full Text] [Related]
20. A novel stealth liposomal topotecan with amlodipine: apoptotic effect is associated with deletion of intracellular Ca2+ by amlodipine thus leading to an enhanced antitumor activity in leukemia.
Li X; Ruan GR; Lu WL; Hong HY; Liang GW; Zhang YT; Liu Y; Long C; Ma X; Yuan L; Wang JC; Zhang X; Zhang Q
J Control Release; 2006 May; 112(2):186-98. PubMed ID: 16516327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
